Talc: Clinical Trials

10 trials of Talc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 unknown, 1 not yet recruiting, 1 terminated. 6 Phase 3, 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 36Completed 5, Withdrawn 1
Not applicable1Not yet recruiting 1
Phase 11Unknown 1
Phase 21Unknown 1
Phase 41Terminated 1

Follow Talc: new trials by email Literature Review of Talc trials Research Report on Talc

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study to Assess Safety, Effectiveness and In-Use Tolerability of Saffron Extract Capsules for Improving Skin Health and Reducing Signs of Aging on Healthy Adult Male and Female Subjects.
Standardized Saffron Extract (Crocus Sativus L) 10 mg Capsule, Placebo (capsules containing Maltodextrin, Calcium carbonate, Sunset yellow, Maize starch, Mg Stearate, Talc) - Wrinkles, Fine Lines
Not applicableNot yet recruitingNovoBliss Research Pvt Ltd502026-01-012026-01-07
Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion
Talc - Malignant Pleural Effusion
Phase 4TerminatedDuke University42021-03-182023-09-28
Dry Pleurodesis With Talcum and Afatinib is Used to Treat Patients With Non-Small Cell Lung Carcinoma
Afatinib, Talcum powder - Non Small Cell Lung Cancer
Phase 1UnknownCenter Trials & Treatment Europe122019-03-052023-04-25
Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication
Progel Sealant, Talcum Powder, Pain Questionnaire - Lung Diseases, Mesothelioma
Phase 3WithdrawnM.D. Anderson Cancer Center2015-12-012015-12-15
Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion
Iodopovidone solution, Talc - Malignant Pleural Effusion
Phase 3CompletedChiang Mai University602015-11-012020-01-23
Phase II Study of CG100649 for Primary Osteoarthritis in Male Subjects
CG100649, Silicified microcrystalline cellulose + talc - Osteoarthritis, Knee, Osteoarthritis, Hip
Phase 2UnknownCrystalGenomics, Inc.2402007-10-012008-06-13
Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma
talc, therapeutic thoracoscopy, therapeutic videothoracoscopy - Malignant Mesothelioma, Metastatic Cancer
Phase 3CompletedPapworth Hospital NHS Foundation Trust1962003-09-012013-06-28
Standard Chest Tube Compared With a Small Catheter in Treating Malignant Pleural Effusion in Patients With Cancer
talc, dyspnea management - Metastatic Cancer, Pulmonary Complications
Phase 3CompletedAlliance for Clinical Trials in Oncology672002-05-012016-07-04
Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions
bleomycin sulfate, doxycycline, talc - Metastatic Cancer
Phase 3CompletedEastern Cooperative Oncology Group4801997-01-102023-06-22
Talc in Treating Patients With Malignant Pleural Effusion
talc, Talc - Metastatic Cancer
Phase 3CompletedAlliance for Clinical Trials in Oncology5011994-12-012016-06-28

Conditions studied

Pleural Effusion, Malignant (6)  ·  Neoplasm Metastasis (4)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Hyperpigmentation (1)  ·  Lung Diseases (1)  ·  Mesothelioma (1)  ·  Mesothelioma, Malignant (1)  ·  Osteoarthritis (1)  ·  Osteoarthritis, Hip (1)  ·  Osteoarthritis, Knee (1)  ·  Solitary Fibrous Tumor, Pleural (1)

Sponsors

Alliance for Clinical Trials in Oncology (2)  ·  Center Trials & Treatment Europe (1)  ·  Chiang Mai University (1)  ·  CrystalGenomics, Inc. (1)  ·  Duke University (1)  ·  Eastern Cooperative Oncology Group (1)  ·  M.D. Anderson Cancer Center (1)  ·  NovoBliss Research Pvt Ltd (1)  ·  Papworth Hospital NHS Foundation Trust (1)

Countries

United States (3)  ·  Canada (1)  ·  Georgia (1)  ·  Germany (1)  ·  Thailand (1)  ·  United Kingdom (1)

Top investigators

Apichat Tantraworasin (1)  ·  Jemi Olak, MD (1)  ·  John C. Ruckdeschel, MD (1)  ·  Nayan Patel (1)  ·  Randolph S. Marks, MD (1)  ·  Reza J. Mehran, MD (1)  ·  Robert Winter, MD (1)  ·  Scott Shofer (1)  ·  Todd Demmy, MD (1)  ·  William K Schmidt, PhD (1)

Results publications

PMID 15764775, PMID 24942631

NIH funding

U10CA031946 (1), U10CA076001 (1)